StockVS

NASDAQ · Packaged Foods · USD

Prenetics Global Limited (PRE) Stock Analysis

Prenetics Global Limited (PRE) is a Packaged Foods stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PRE

$16.73

−$1.90 (−10.20%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PRE with… →

PRE Key Statistics

As of Oct 21, 2026
Trading
Open
$18.98
Previous Close
$18.63
Day's Range
16.35–18.98
52-Week Range
11.37–27.24
Volume
292.14K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.35
Valuation
Market Cap
$326.47M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.11
EPS (ttm)Profit attributable to each share over the last twelve months.
−3.10
Financials (FY)
Revenue (FY)
$92.39M+479.76%
Net Income (FY)
−$37.71M
Profit marginThe share of revenue left as profit after all costs and taxes.
−30.40%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
17.93M
1-Year Return
+1.15%
Dividend and dates
Earnings Date
November 10, 2026
Avg Volume
207.27K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PRE closed at $16.73, +1.15% over 1 year.

Prenetics Global Limited (PRE) has a market capitalization of $326.47M.

In fiscal 2025, PRE reported revenue of $92.39M.

PRE Stock Return by Calendar Year

Prenetics Global Limited (PRE) return since Jul 2021: what $10,000 became

1 year
$10,000 $10,115
+1.15%
5 years
$10,000 $1,455
−85.45%
Since Jul 2021
$10,000 $1,434
−85.66%

If you had invested $10,000 in Prenetics Global Limited (PRE) at the close on July 16, 2021, the earliest close on record here, it would have been worth $1,434 at the close on October 21, 2026: −85.66% in total, −30.84% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+6.22%
2025+171.55%
2024−1.86%
2023−80.30%
2022−73.97%
2021 (partial year)−1.20%

As of October 21, 2026.

PRE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$92.39M−$37.71M−40.8%
2024$15.94M−$46.30M−290.6%
2023$6.16M−$62.72M−1,019.1%
2022$13.16M−$190.45M−1,446.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$92.39M$48.79M−$38.13M−$37.71M−40.8%
2024$15.94M$9.28M−$38.28M−$46.30M−290.6%
2023$6.16M$1.17M−$42.47M−$62.72M−1,019.1%
2022$13.16M$3.62M−$65.92M−$190.45M−1,446.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PRE Valuation vs Packaged Foods Median

Median of 70 stocks
MetricPREPackaged Foods medianvs median
P/S ratio2.110.673.2x the median
Profit margin−30.40%2.27%32.7 pts below

Medians across 70 Packaged Foods stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Prenetics Global Limited (PRE) carries a market capitalisation of $326.47M. It is classified in the Packaged Foods industry, within the Consumer Defensive sector. Headcount on file is 98.

Over the past 52 weeks the price has ranged from $11.37 to $27.24. PRE last closed at $16.73 on October 21, 2026. That is −$1.90 (−10.20%) against the previous close. The latest close sits 47.21% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $92.39M. That is +479.76% against the prior fiscal year, when revenue was $15.94M. The same year closed with a net loss of $37.71M. Profit margin runs at −30.4%. That is 32.7 percentage points below the Packaged Foods median of 2.27%. Trailing earnings per share are −3.1.

Across the 4 fiscal years on file, revenue moves from $13.16M in 2022 to $92.39M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 2.11. On price-to-sales that is 3.2 times the Packaged Foods median of 0.67. 70 Packaged Foods companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +1.15%. Across 5 years the annualized return works out at −31.99%. Beta against the wider market is reported at 0.35. Annualized volatility over the trailing 5 years is 82.67%.

Growth & Income

No dividend is on file for PRE.

2026 is still running; the total return is +6.22% year to date. Across the complete calendar years on file, 2025 returned +171.55% and 2023 returned −80.30%. Of the 4 complete calendar years on file, 1 finished higher.

Peer Comparison

Prenetics Global Limited (PRE) operates in the Packaged Foods industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Prenetics Global Limited PRE $326.47M —
The Kraft Heinz Company KHC $27.87B —
General Mills, Inc. GIS $17.41B —
Saputo Inc. SAP.TO CA$16.14B 23.7

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Packaged Foods industry average P/E ratio is 14.5x. Prenetics Global Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Packaged Foods Stocks

View all Packaged Foods stocks →

Popular Consumer Defensive Stocks

View all Consumer Defensive stocks →

About Prenetics Global Limited

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Visit website →